Summary
The Otsuka Long-Evans Tokushima Fatty rat is a new inbred obese strain with a late onset and chronic course of spontaneous hyperglycaemia in the male, and is considered to be a model of non-insulin-dependent diabetes mellitus [1, 2]. Fat distribution analysis showed a typical accumulation of intra-abdominal visceral fat in Otsuka Long-Evans Tokushima Fatty rats compared with a control strain, Long-Evans Tokushima Otsuka rats. To examine the insulin sensitivity of Otsuka Long-Evans Tokushima Fatty rats, we performed euglycaemic hyperinsulinaemic clamp experiments in vivo in rats under anaesthesia on this strain and on Long-Evans Tokushima Otsuka rats. The Otsuka Long-Evans Tokushima Fatty rats showed lower values for the glucose infusion rate (60% of the control at 12 weeks old and 20–30% of the control at 18, 24, 30 and 39 weeks old) than age-matched controls, indicating the development of insulin resistance with age. Hindlimb perfusion experiments in vitro also showed a 45% decrease of insulin-stimulated glucose uptake in Otsuka Long-Evans Tokushima Fatty rats in the diabetic stage. These results indicate that insulin resistance exists in the skeletal muscle of Otsuka Long-Evans Tokushima Fatty rats. To obtain information on the mechanism of insulin resistance in the skeletal muscle of Otsuka Long-Evans Tokushima Fatty rats, the insulin binding, autophosphorylation and tyrosine kinase activity of their partially-purified insulin receptors in vitro were compared with those from control rats. The results showed no marked differences in these insulin receptor functions between diabetic and control rats. These results suggest that it is unlikely that severe insulin-receptor dysfunction is responsible for the insulin resistance in the skeletal muscle of Otsuka Long-Evans Tokushima Fatty rats.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- OLETF:
-
Otsuka Long-Evans Tokushima Fatty
- LETO:
-
Long-Evans Tokushima Otsuka
- ECL:
-
enhanced chemiluminescence
- Kd :
-
dissociation constant
- Bmax :
-
maximal binding
- BSA:
-
bovine serum albumin
References
Kawano K, Hirashima T, Mori S, Kurosumi M, Saitoh Y (1991) A new rat strain with non-insulin dependent diabetes mellitus, “OLETF“. Rat News Lett 25: 24–26
Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T (1992) Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41: 1422–1428
Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S (1987) Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36: 54–59
Fujioka S, Matsuzawa Y, Tokunaga K et al. (1991) Improvement of glucsoe and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 15: 853–859
Björntorp P (1991) Metabolic implications of body fat distribution. Diabetes Care 14: 1132–1143
Kahn CR, White MF (1988) The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 82: 1151–1156
Kasuga M, Karlsson FA, Kahn CR (1982) Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215: 185–187
Rosen OM (1987) After insulin binds. Science 237: 1452–1458
Morgan DO, Ho L, Korn LJ, Roth RA (1986) Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc Natl Acad Sci USA 83: 328–332
Ellis L, Clauser E, Morgan DO, Edery M, Roth RA, Rutter WJ (1986) Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45: 721–732
Chou CK, Dull TJ, Russell DS et al. (1987) Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J Biol Chem 262: 1842–1847
Obermaier-Kusser B, White MF, Pongratz DE et al. (1989) A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. J Biol Chem 264: 9497–9504
Arner P, Pollare T, Lithell H, Livingston JN (1987) Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 437–440
Caro JF, Sinha MK, Raju SM et al. (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330–1337
Nyomba BL, Ossowski VM, Bogardus C, Mott DM (1990) Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. Am J Physiol 258: E964-E967
Ruderman NB, Houghton CRS, Hems R (1971) Evaluation of the isolated perfused rat hindquarter for the study of muscle metabolism. Biochem J 124: 639–651
Burant CF, Treutelaar MK, Landreth GE, Buse MG (1984) Phosphorylation of insulin receptors solubilized from rat skeletal muscle. Diabetes 33: 704–708
Freidenberg GR, Suter SL, Henry RR, Reichart D, Olefsky JM (1991) In vivo stimulation of the insulin receptor kinase in human skeletal muscle. J Clin Invest 87: 2222–2229
Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principal of protein-binding. Anal Biochem 72: 248–254
Burant CF, Treutelaar MK, Buse MG (1986) Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle. J Clin Invest 77: 260–270
Rijksen G, van Oirschot BA, Staal GEJ (1991) Nonradio-active assays of protein tyrosine kinase activity using antiphosphotyrosine antibodies. Methods Enzymol 200: 98–107
Shima K, Shi K, Sano T, Iwami T, Mizuno A, Noma Y (1993) Is exercise training effective in preventing diabetes mellitus in the Otsuka-Long-Evans-Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus? Metabolism 42: 971–977
Olefsky JM, Kolterman OG, Scarlett JA (1982) Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 243: E15-E30
Ishida T, Chap Z, Chou J et al. (1984) Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs. Diabetes 33: 984–990
Friedman JE, Dohm GL, Leggett-Frazier N et al. (1992) Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. J Clin Invest 89: 701–705
Vicario P, Brady EJ, Slater EE, Saperstein R (1987) Insulin receptor tyrosine kinase activity is unaltered in ob/ob and db/db mouse skeletal muscle membranes. Life Sci 41: 1233–1241
Kobayashi M, Iwanishi M, Egawa K, Shigeta Y (1992) Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41: 476–483
Slieker LJ, Roberts EF, Shaw WN, Johnson WT (1990) Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats. Diabetes 39: 619–625
Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet I: 785–789
Svedberg J, Björntorp P, Smith U, Lönnroth P (1990) Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39: 570–574
Hennes MMI, Shrago E, Kissebah AH (1990) Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obes 14: 831–841
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sato, T., Asahi, Y., Toide, K. et al. Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM. Diabetologia 38, 1033–1041 (1995). https://doi.org/10.1007/BF00402172
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00402172